Towards Realizing Virtual Clinical Trials for Optimization and Evaluation of Breast Imaging Systems

Loading...

Date

2014

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

365
views
507
downloads

Abstract

It is essential that breast cancer be detected at its earliest stages for better prognosis. Advanced imaging techniques and systems are constantly under development and study to improve the screening and detection of breast cancer. Like every technological advancement in medical care, these techniques and systems need to be tested and verified before their clinical translation. What are currently considered the gold standard for justification of clinical translation are randomized clinical trials. Clinical trials are time-consuming, costly, and expose the population to extra irradiation in the case of x-ray imaging. Given the recent advances in computation and modeling, virtual clinical trials can be carefully designed and carried out to inform, orient, or potentially replace clinical trials given adequate validation and credibility. This dissertation elaborates on the design, implementation, and performance analysis of virtual clinical trials, which is made possible through the employment and advancement of sophisticated tools and models.

Description

Provenance

Subjects

Electrical engineering, Medical imaging and radiology, Biomedical engineering, Breast imaging, Breast Models, Detection Theory, Medical imaging, Signal and Image Processing, System Modeling

Citation

Citation

Kiarashi, Nooshin (2014). Towards Realizing Virtual Clinical Trials for Optimization and Evaluation of Breast Imaging Systems. Dissertation, Duke University. Retrieved from https://hdl.handle.net/10161/9101.

Collections


Except where otherwise noted, student scholarship that was shared on DukeSpace after 2009 is made available to the public under a Creative Commons Attribution / Non-commercial / No derivatives (CC-BY-NC-ND) license. All rights in student work shared on DukeSpace before 2009 remain with the author and/or their designee, whose permission may be required for reuse.